Lotem, J <br/><br/>
Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Oct 1996 
 - 12507-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0027-8424 
<br/><br/><label>Standard No.: </label>10.1073/pnas.93.22.12507  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Chloromethyl Ketones--pharmacology<br/>Apoptosis--drug effects<br/>Butylated Hydroxyanisole--pharmacology<br/>Caspase 1<br/>Cathepsin B--pharmacology<br/>Cathepsin L<br/>Cathepsins--pharmacology<br/>Cysteine Endopeptidases--metabolism<br/>Cytokines--pharmacology<br/>Endopeptidases<br/>Enzyme Precursors--metabolism<br/>Granulocyte-Macrophage Colony-Stimulating Factor--pharmacology<br/>Granzymes<br/>Humans<br/>Interferon-gamma--pharmacology<br/>Interleukin-6--pharmacology<br/>Oligopeptides--pharmacology<br/>Pepstatins--pharmacology<br/>Protease Inhibitors--pharmacology<br/>Serine Endopeptidases--pharmacology<br/>Tosyllysine Chloromethyl Ketone--pharmacology<br/>Tosylphenylalanyl Chloromethyl Ketone--pharmacology<br/>Tumor Cells, Cultured--drug effects<br/>Tumor Suppressor Protein p53--pharmacology